Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.54 CAD | -0.65% | +1.99% | +105.33% |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Capitalization 1 | 61.13 | 30.05 | 65.99 | 176 | - | - |
Enterprise Value (EV) 1 | 55.71 | 35.67 | 65.99 | 176 | 176 | 176 |
P/E ratio | -3.79 x | -1.43 x | -1.36 x | -14 x | -17.1 x | -30.8 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 1.28 x | 0.56 x | 9.02 x | 8.27 x | 6.12 x | 4.58 x |
EV / Revenue | 1.28 x | 0.56 x | 9.02 x | 8.27 x | 6.12 x | 4.58 x |
EV / EBITDA | -13.2 x | -3.21 x | -8.3 x | -28.4 x | -146 x | 50.3 x |
EV / FCF | -7,707,886 x | -3,470,216 x | - | - | - | - |
FCF Yield | -0% | -0% | - | - | - | - |
Price to Book | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 48,905 | 50,075 | 87,987 | 114,265 | - | - |
Reference price 2 | 1.250 | 0.6000 | 0.7500 | 1.540 | 1.540 | 1.540 |
Announcement Date | 3/31/22 | 3/31/23 | 3/28/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 46.29 | 38.57 | 47.82 | 53.22 | 7.317 | 21.29 | 28.74 | 38.4 |
EBITDA 1 | - | 4.518 | -4.644 | -9.356 | -7.954 | -6.195 | -1.203 | 3.5 |
EBIT | - | -3.294 | -15.06 | - | -16.82 | - | - | - |
Operating Margin | - | -8.54% | -31.5% | - | -229.85% | - | - | - |
Earnings before Tax (EBT) 1 | - | - | -16.29 | - | -32.68 | -13.96 | -7.392 | - |
Net income 1 | -0.1203 | - | -15.67 | - | -31.54 | -13.96 | -7.392 | - |
Net margin | -0.26% | - | -32.77% | - | -431.12% | -65.58% | -25.72% | - |
EPS 2 | - | - | -0.3300 | -0.4200 | -0.5500 | -0.1100 | -0.0900 | -0.0500 |
Free Cash Flow | - | 4.137 | -7.931 | -8.658 | - | - | - | - |
FCF margin | - | 10.73% | -16.59% | -16.27% | - | - | - | - |
FCF Conversion (EBITDA) | - | 91.57% | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 12/11/20 | 3/30/21 | 3/31/22 | 3/31/23 | 3/28/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 12.64 | 13.94 | 13.02 | 13.81 | 12.59 | 13.8 | - | 2.753 | 1.921 | 3.9 | 5.006 | 5.748 | 6.278 | 4.6 |
EBITDA 1 | -1.824 | -1.514 | -2.421 | -2.936 | -2.152 | -1.789 | - | -4.535 | -1.464 | -2.539 | -1.106 | -0.889 | -0.5595 | -1.4 |
EBIT | -5.33 | -4.551 | -4.763 | -5.064 | -5.119 | - | - | - | -3.886 | - | - | - | - | - |
Operating Margin | -42.16% | -32.66% | -36.58% | -36.66% | -40.67% | - | - | - | -202.29% | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -5.47 | -4.691 | -5.037 | -5.445 | -5.588 | - | - | -7.771 | -6.107 | -5.289 | -3.143 | -2.961 | -2.569 | - |
Net income 1 | -5.438 | -4.94 | -4.322 | -4.229 | -9.1 | - | -9.805 | -7.791 | -6.311 | -5.289 | -3.143 | -2.961 | -2.569 | - |
Net margin | -43.02% | -35.45% | -33.2% | -30.61% | -72.3% | - | - | -283% | -328.53% | -135.6% | -62.78% | -51.51% | -40.92% | - |
EPS 2 | -0.1100 | -0.1000 | -0.0900 | -0.0800 | -0.1800 | -0.0700 | -0.1800 | - | -0.0900 | -0.0300 | -0.0300 | -0.0300 | -0.0200 | - |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 11/15/21 | 3/31/22 | 5/16/22 | 8/15/22 | 11/14/22 | 3/31/23 | 8/15/23 | 11/14/23 | 3/28/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt | - | - | - | 5.62 | - | - | - | - |
Net Cash position | - | - | 5.42 | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | -0.601 x | - | - | - | - |
Free Cash Flow | - | 4.14 | -7.93 | -8.66 | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex | - | 0.09 | 0.83 | 0.31 | 0.07 | - | - | - |
Capex / Sales | - | 0.22% | 1.74% | 0.59% | 0.9% | - | - | - |
Announcement Date | 12/11/20 | 3/30/21 | 3/31/22 | 3/31/23 | 3/28/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+105.33% | 129M | |
-20.16% | 16.21B | |
+4.50% | 12.44B | |
+3.98% | 11.58B | |
+9.72% | 10.79B | |
-2.19% | 7.68B | |
+18.43% | 7.2B | |
+4.49% | 6.67B | |
+50.89% | 4.66B | |
-5.12% | 4.25B |
- Stock Market
- Equities
- AIDX Stock
- Financials Healwell AI Inc.